---
title: "William Blair downgrades Lifecore Biomedical (LFCR) to a Hold"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300331252.md"
description: "Lifecore Biomedical received a Hold rating and price target from William Blair analyst Jared Haase today. Haase covers the Healthcare sector, focusing on stocks such as Addus Homecare, Lifecore Biomedical, and Fortrea Holdings Inc.. According to TipRanks, Haase has an average return of 16.3% and a 69.05% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Lifecore Biomedical with a $6.25 average price target."
datetime: "2026-09-28T16:36:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300331252.md)
  - [en](https://longbridge.com/en/news/300331252.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300331252.md)
generator: "portal-rs"
---

# William Blair downgrades Lifecore Biomedical (LFCR) to a Hold

Lifecore Biomedical received a Hold rating and price target from William Blair analyst Jared Haase today.

Haase covers the Healthcare sector, focusing on stocks such as Addus Homecare, Lifecore Biomedical, and Fortrea Holdings Inc.. According to TipRanks, Haase has an average return of 16.3% and a 69.05% success rate on recommended stocks. 

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Lifecore Biomedical with a $6.25 average price target.

### Related Stocks

- [LFCR.US](https://longbridge.com/en/quote/LFCR.US.md)
- [ADUS.US](https://longbridge.com/en/quote/ADUS.US.md)
- [FTRE.US](https://longbridge.com/en/quote/FTRE.US.md)

## Related News & Research

- [Lifecore Biomedical merger receives early termination of US antitrust waiting period](https://longbridge.com/en/news/304460335.md)
- [Lifecore Biomedical GAAP EPS of -$1.08 misses by $0.98, revenue of $25.3M misses by $13.31M](https://longbridge.com/en/news/304416307.md)
- [Lifecore Biomedical Q3 revenue misses estimates as CDMO, HA sales decline](https://longbridge.com/en/news/304274446.md)
- [‘Same Old Story,’ Says Investor About Rocket Lab Stock](https://longbridge.com/en/news/305045505.md)
- [The Buffett Indicator Is Flashing Red. These 3 Dividend Stocks Could Be Safe Havens.](https://longbridge.com/en/news/304985751.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**